Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Saved in:
| Title: | Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer. |
|---|---|
| Authors: | Lorusso, Domenica1,2 (AUTHOR) kettalorusso@libero.it, Guy, Holly3 (AUTHOR) holly.guy@fiecon.com, Samyshkin, Yevgeniy4 (AUTHOR) yevgeniy.x.samyshkin@gsk.com, Hawkes, Carol4 (AUTHOR) carol.l.hawkes@gsk.com, Estenson, Kasey5,6 (AUTHOR) kasey.x.estenson@gsk.com, Coleman, Robert L.7 (AUTHOR) robert.coleman@mckesson.com |
| Source: | Cancers. Mar2022, Vol. 14 Issue 5, p1285. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 155707483 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lorusso%2C+Domenica%22">Lorusso, Domenica</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> kettalorusso@libero.it</i><br /><searchLink fieldCode="AR" term="%22Guy%2C+Holly%22">Guy, Holly</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> holly.guy@fiecon.com</i><br /><searchLink fieldCode="AR" term="%22Samyshkin%2C+Yevgeniy%22">Samyshkin, Yevgeniy</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> yevgeniy.x.samyshkin@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Hawkes%2C+Carol%22">Hawkes, Carol</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> carol.l.hawkes@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Estenson%2C+Kasey%22">Estenson, Kasey</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<i> kasey.x.estenson@gsk.com</i><br /><searchLink fieldCode="AR" term="%22Coleman%2C+Robert+L%2E%22">Coleman, Robert L.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<i> robert.coleman@mckesson.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. Mar2022, Vol. 14 Issue 5, p1285. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=155707483 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers14051285 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: 1285 Titles: – TitleFull: Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lorusso, Domenica – PersonEntity: Name: NameFull: Guy, Holly – PersonEntity: Name: NameFull: Samyshkin, Yevgeniy – PersonEntity: Name: NameFull: Hawkes, Carol – PersonEntity: Name: NameFull: Estenson, Kasey – PersonEntity: Name: NameFull: Coleman, Robert L. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: Mar2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 20726694 Numbering: – Type: volume Value: 14 – Type: issue Value: 5 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |
